FDA
-
-
-
-
-
-
-
Ikena Oncology Provides Research & Development Update on IK-930 Program Targeting the Hippo Pathway
-
-
-
-
-
-
-
Ikena Oncology Reports Third Quarter 2021 Financial Results and Corporate Update
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

